Matthew Kaskavitch 👨🏻‍💻

Creating data-driven digital engagement strategy, speaker, technologist, former faculty, proud dad and hockey lover.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

The pandemic has accelerated the digital engagement transition. If you’re not investing in designing proper digital experiences you’re being left behind, way behind.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

@shyannrachael Say what?

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Does AI take this problem and make it worse by scaling it 100x faster? I feel it does.

What say you, @LaurenHug?

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

For the big questions in life I always consult the smartest people I know. (@LaurenHug)

While AI seems very useful in many ways it’s use in content creation is troubling. We already have way too much information. It’s causing catastrophic issues in society. 1/2

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

@LaurenHug I’m conflicted. Organic reach being what it is the paid side of social is a necessity. We used paid heavily during our Waldo Canyon efforts to engage the community in various ways — but that was a very different time in our perception and interaction with these platforms.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Proud to work for a company that puts patients first and is committed to developing clinical evidence! Check out the ABRE clinical study 36-month outcomes! #MedtronicEmployee https://t.co/kKjfWKrkbc

[Medtronic Vascular Health @MDTVascular]

Mid-40s man w/rectal carcinoma metastatic to liver. Y-90 performed because of suboptimal response to chemotherapy & hopes of controlling his liver disease.

Cases iBrochure: https://t.co/EMHMQYzXid
Risk info: https://t.co/BsbJxEuDIL

Share your #ConcertoPatient case! | #IRad

[Medtronic Vascular Health @MDTVascular]

ABRE Study clinical outcomes through 36 months coming up in a first to podium presentation at @myAVLS! Join @UkVenous on Friday, October 14th and sign up to receive the data! https://t.co/q1Ln9EJy36

#IRad #TwittIR #VascularSurgery #InterventionalCardiology

[Medtronic Vascular Health @MDTVascular]

ABRE study 36-month outcomes for release soon from @UkVenous! Clinical evidence: 10/14 at @myAVLS. Clinical evidence by initial clinical presentation: 10/31 at @TheVEINSatVIVA.

Sign up to receive the data --> https://t.co/Lk5isEMhDm

#IRad #TwittIR #VascularSurgery

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

It's amazing to see the impact the VenaSeal™ closure system can have in the lives of patients. I'm so proud to work at Medtronic and be involved in this important work. #MedtronicEmployee https://t.co/C9tNOUU74K

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

I've heard of peripheral arterial disease (PAD) but I didn't really know much about it till now. For #PADAwarenessMonth, I'm sharing a short assessment you can take to learn if you're at risk for PAD and the most common symptoms. #MedtronicEmployee https://t.co/zKDpuHfEiv

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Have you heard of PAD? It's one of the most common diseases among Americans 50+, but it's not well known. In recognition of #PADAwarenessMonth, I took this assessment to learn if I'm at risk. Feel free to share with your own network. #MedtronicEmployee https://t.co/vuAklNKVd1

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

@mntwinsfan07 Wooooooo

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Channeling my inner @mntwinsfan07 tonight from the suite. #MNTwins

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Thank you so much @amberbalcaen10 — tough night out there, but you made this boy’s year with your autograph!

He says he now has *two* favorite drivers. Kyle Busch and Amber Balcaen! #ARCA

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

@mbrinkerhoff @RyanAmirault You’ve hit it on the head. $15/gallon would ruin millions and millions of Americans who don’t live in urban areas nor have access to public transport. I’d never wish for that.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

The Buffalo shooting will be an important case for understanding the digital challenges we face. The amount of information we have on the shooter’s mindset and how he was radicalized via social media is unique.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

I’m once again here to say self-reinforcing feedback loops via content algorithms is still a massive problem in society.

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

It's great to see Dr. Austin Chiang's influence at work. In this episode of the #MedtronicTalks podcast, he shines a light on new advances in the GI space, and Medtronic's role in introducing new innovations for patients. #MedtronicEmployee https://t.co/6kqHVWt9qA

[Matthew Kaskavitch 👨🏻‍💻 @socialmatt]

Our commitment to clinical evidence distinguishes Medtronic. Publication of 12-month clinical study data for the Abre™ venous self-expanding stent system is just one more example of this commitment. #MedtronicEmployee https://t.co/prI4cza8Yn

[Medtronic Vascular Health @MDTVascular]

March is #NationalKidneyMonth. We're committed to help end-stage kidney disease (#ESKD) patients get and maintain access to critical dialysis. ❤️